G. Kalkum

Increase in left ventricular mass index and acroparesthesia incidence in children with Fabry disease correlates with their GLA mutation

U. Ramaswami, G. Pintos-Morell, A. Gal, 2013 .

Fabry disease in children and response to enzyme replacement therapy: results from the Fabry Outcome Survey

U. Ramaswami, G. Pintos-Morell, M. Beck, 2012, Clinical genetics.

Ocular Signs Correlate Well with Disease Severity and Genotype in Fabry Disease

N. Karabul, A. Gal, A. Sodi, 2015, PloS one.

Successful long‐term enzyme replacement therapy in a young adult with Fabry disease

C. Whybra, M. Beck, C. Kampmann, 2013, Clinical genetics.

Paediatric Fabry disease: prognostic significance of ocular changes for disease severity

U. Ramaswami, N. Karabul, G. Pintos-Morell, 2016, BMC Ophthalmology.

Measuring patient experiences in Fabry disease: validation of the Fabry-specific Pediatric Health and Pain Questionnaire (FPHPQ)

D. Stull, I. Wiklund, U. Ramaswami, 2012, Health and Quality of Life Outcomes.

Enzyme replacement therapy with agalsidase alfa in pregnant women with Fabry disease.

H. Kölbl, M. Beck, D. Macchiella, 2009, European journal of obstetrics, gynecology, and reproductive biology.